Business
Peloton
Getty Images
Riding low

Peloton drops after posting another quarter of falling sales

Equipment sales sank 27% as the fitness company posted a third straight year-over-year decline in revenue.

Claire Yubin Oh

Peloton’s shares were feeling the burn in early trading on Thursday after the company reported its third straight year-over-year decline in sales in its Q3 results.

Wall Street’s analysts achieved that rare thing: predicting the connected fitness company’s $624 million revenue on the number, while gross profit came in at $318 million, above the $314 million consensus compiled by FactSet. But despite technically meeting sell-side expectations, investors seemed uncomfortable with the continued decline in sales, which dropped 13% year over year. The company’s equipment sales dropped significantly, down 27%.

Peloton’s all-important high-margin subscription service was a bright spot in the print, reaching 2.88 million paid subscriptions. But growth for that business looks unlikely, with company guidance implying at its midpoint that the number of subscriptions will have dropped 7% by the end of fiscal year 2025, relative to 2024.

Peloton is dependent on its subscription business
Sherwood News

Shifting gears

After years of trying to convince customers to splurge thousands on its indoor bikes, Peloton has pivoted to focus on profitability, specifically its money-making services business — including hiring a new CEO known for managing subscription services at Apple and Ford, and rolling out more on-demand member events. This quarter, a whopping 91% of the company’s gross income came from its subscription segment, marking Peloton’s 16th straight quarter of making most of its money from its members, not machines.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.